Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
504 questions in 57 reviews · Kidney and Transplant
current versionsNo studies 504 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Hypoxia‐inducible factor (HIF) stabilisers vs placebo Life participation · people with CKD (including HD and PD) Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease (2022) · Cochrane | no estimate extracted | NR | No studies |
Aerobic exercise vs no exercise or placebo exercise Cardiovascularevents · adults undergoing maintenance dialysis Exercise training for adults undergoing maintenance dialysis (2022) · Cochrane | no estimate extracted | NR | No studies |
Resistance exercise vs no exercise or placebo exercise Death (any cause) · adults undergoing maintenance dialysis Exercise training for adults undergoing maintenance dialysis (2022) · Cochrane | no estimate extracted | NR | No studies |
Resistance exercise vs no exercise or placebo exercise Cardiovascular events · adults undergoing maintenance dialysis Exercise training for adults undergoing maintenance dialysis (2022) · Cochrane | no estimate extracted | NR | No studies |
Any exercise vs no exercise or placebo exercise Cardiovascularevents · adults undergoing maintenance dialysis Exercise training for adults undergoing maintenance dialysis (2022) · Cochrane | no estimate extracted | NR | No studies |
Combined aerobic and resistance exercise vs no exercise or placebo exercise Death (any cause) · adults undergoing maintenance dialysis Exercise training for adults undergoing maintenance dialysis (2022) · Cochrane | no estimate extracted | NR | No studies |
Combined aerobic and resistance exercise vs no exercise or placebo exercise Cardiovascular events · adults undergoing maintenance dialysis Exercise training for adults undergoing maintenance dialysis (2022) · Cochrane | no estimate extracted | NR | No studies |
Combined aerobic and resistance exercise vs no exercise or placebo exercise Fatigue · adults undergoing maintenance dialysis Exercise training for adults undergoing maintenance dialysis (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs placebo GI function · adult solid organ transplant recipients (kidney) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Probiotics vs placebo Death · adult solid organ transplant recipients (liver) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs prebiotics GI function · adult solid organ transplant recipients (liver) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs prebiotics Graft health · adult solid organ transplant recipients (liver) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs placebo Graft health · adult solid organ transplant recipients (kidney) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs placebo Adverse events · adult solid organ transplant recipients (kidney) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs placebo Serious adverse events · adult solid organ transplant recipients (kidney) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs placebo Death · adult solid organ transplant recipients (kidney) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Probiotics vs placebo GI function · adult solid organ transplant recipients (liver) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Probiotics vs placebo Graft health · adult solid organ transplant recipients (liver) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Probiotics vs placebo Adverse events · adult solid organ transplant recipients (liver) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Probiotics vs placebo Serious adverse events · adult solid organ transplant recipients (liver) Synbiotics, prebiotics and probiotics for solid organ transplant recipients (2022) · Cochrane | no estimate extracted | NR | No studies |
Resistance (anaerobic) exercise training vs usual care or no exercise training Maximal and functional exercise capacity · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Resistance (anaerobic) exercise training vs another form of resistance (anaerobic) exercise training Pulmonary function · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Resistance (anaerobic) exercise training vs another form of resistance (anaerobic) exercise training Pathological bone fractures · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Resistance (anaerobic) exercise training vs usual care or no exercise training HRQoL · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Multimodal exercise training vs usual care or no exercise training Pathological bone fractures · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Fourteen‐weeks vs 7‐weeks multimodal exercise training Pathological bone fractures · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Resistance (anaerobic) exercise training vs usual care or no exercise training Pulmonary function · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Resistance (anaerobic) exercise training vs usual care or no exercise training Death (any cause) · adult lung transplant recipients Exercise training for adult lung transplant recipients (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Home dialysis · people with CKD Urgent‐start peritoneal dialysis versus haemodialysis for people with chronic kidney disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Bovine colostrum vs placebo Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Synsorb Pk vs placebo Adverse events · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Synsorb Pk vs placebo Need for acute dialysis · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Synsorb Pk vs placebo Neurological complications · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Synsorb Pk vs placebo Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Urtoxazumab (3.0 mg/kg) vs placebo Need for acute dialysis · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs no treatment Adverse events · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Urtoxazumab (1.0 mg/kg) vs placebo Need for acute dialysis · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs no treatment Need for acute dialysis · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs no treatment Neurological complications · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs no treatment Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Bovine colostrum vs placebo Need for acute dialysis · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Bovine colostrum vs placebo Neurological complications · patients with diarrhoea due to Shiga toxin‐producing E. coli Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome (2021) · Cochrane | no estimate extracted | NR | No studies |
Any weight loss intervention vs usual care or control Death (any cause) · people with CKD who are overweight or obese Interventions for weight loss in people with chronic kidney disease who are overweight or obese (2021) · Cochrane | no estimate extracted | NR | No studies |
Any weight loss intervention vs usual care or control Cardiovascular events · people with CKD who are overweight or obese Interventions for weight loss in people with chronic kidney disease who are overweight or obese (2021) · Cochrane | no estimate extracted | NR | No studies |
CVVHD vs CVVH or CVVHDF Circuit lifespan · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Pre‐dilution vs post‐dilution (as defined by study investigators) Death from any cause at day 28 of · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Pre‐dilution vs post‐dilution (as defined by study investigators) Recovery of kidney function · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Pre‐dilution vs post‐dilution (as defined by study investigators) Vascular access complications · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Higher blood flow vs standard blood flow Death from any cause at day 28 of · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |
Higher blood flow vs standard blood flow Recovery of kidney function · AKI patients receiving CKRT Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… (2021) · Cochrane | no estimate extracted | NR | No studies |